Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

NCT00493441 is registered in ClinicalTrials.gov with Vertex Pharmaceuticals Incorporated as lead sponsor.

NCT NCT00493441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
Lead sponsor
Vertex Pharmaceuticals Incorporated
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2007
Completion date
December 31, 2009
Enrollment
28 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer